Showing results (31-40 of 210) with videos related to

Sort By:
Pageof 21
Trials|September 30, 2008
European trial of free light chain removal by extended haemodialysis in cast nephropathy (EuLITE): a randomised control trialColin A Hutchison, Mark Cook, Nils Heyne, et al.
AJR. American Journal of Roentgenology|February 26, 2015
Dual-energy CT: virtual calcium subtraction for assessment of bone marrow involvement of the spine in multiple myelomaChristoph Thomas, Christoph Schabel, Bernhard Krauss, et al.
World Journal of Surgical Oncology|September 17, 2025
Sarcopenia and fat loss from serial CT predict survival in multiple myeloma patients undergoing stem cell transplantationJulian Kylies, Elias Brauneck, Matthias Priemel, et al.
Annals of Hematology|July 15, 2026
Simultaneous onset of familial hemophagocytic lymphohistiocytosis and T-cell large granular lymphocytic leukemia in an adultFriederike Dierks, Finn-Ole Paulsen, Kai Lehmberg, et al.
European Journal of Haematology|July 1, 2022
Real-world study on adoption of standard-of-care for transplant-eligible newly diagnosed multiple myeloma patients between 2017 and 2020/2021 across France, Germany, Spain, and ItalyKatja Weisel, Astrid Ottosson Wadlund, Guntug Gungor, et al.
Journal of Ultrasound in Medicine : Official Journal of the American Institute of Ultrasound in Medicine|September 26, 2013
Role of dynamic contrast-enhanced sonography for characterization and monitoring of extramedullary myeloma: comparison with serologic dataJan P Pintoffl, Katja Weisel, Maximilian Schulze, et al.
European Radiology|November 25, 2016
Improved MDCT monitoring of pelvic myeloma bone disease through the use of a novel longitudinal bone subtraction post-processing algorithmMarius Horger, Wolfgang M Thaiss, Hendrik Ditt, et al.
Brain & Spine|July 12, 2026
Multiple myeloma with spinal involvement: Renal dysfunction and albuminuria are associated with progressive sarcopenia in a longitudinal CT morphometric studyJulian Kylies, Dominik Kylies, Katja Weisel, et al.
Clinical Lymphoma, Myeloma & Leukemia|March 28, 2025
Real-World Data on Outcome of Burkitt Lymphoma and Burkitt Leukemia Treated According to the GMALL B-ALL/NHL 2002 Protocol: A Tertiary Center ExperienceRicardo Kosch, Christoph Schaefers, Christian Frenzel, et al.
Human Pathology|May 7, 2013
The BCL2 E17 and SP66 antibodies discriminate 2 immunophenotypically and genetically distinct subgroups of conventionally BCL2-"negative" grade 1/2 follicular lymphomasPatrick Adam, Rosalie Baumann, Janine Schmidt, et al.
Pageof 21